UAE eases drug laws: No jail for bringing in THC, reduced sentences for first-time drug offenders
The reforms come as part of a wider legal overhaul announced as the UAE celebrates a half-century since its founding and seeks to boost its image as a cosmopolitan hub
Dubai: The United Arab Emirates has eased some of its harsh drug laws, relaxing penalties for travelers who arrive in the country with products containing THC, the main intoxicating chemical in cannabis.
The new law, published Sunday in the UAE’s official gazette, says people caught carrying food, drinks and other items with cannabis into the country will no longer land in prison if it's their first time.
Instead, authorities will confiscate and destroy the products.
The law marks a noteworthy change for one of the world’s most restrictive nations when it comes to importing common drugs for personal use, from cannabis to over-the-counter medications like narcotics, sedatives and amphetamines.
The country strictly prohibits the sale and trafficking of drugs, with drug use punishable by four years in jail.
Other changes include reducing minimum sentences from two years to three months for first-time drug offenders and offering convicts rehabilitation at a detention facility separate from other felons.
Foreign drug users who are caught are typically deported to their home countries after imprisonment, but the new law leaves that decision up to the judge.
The reforms come as part of a wider legal overhaul announced as the UAE celebrates a half-century since its founding and seeks to boost its image as a cosmopolitan hub attractive to tourists and investors.
For decades, the nation’s penal code, based on Islamic law, or Shariah, has routinely landed expats and tourists in jail for offenses that few Westerners would otherwise consider crimes.
The news comes as Omicron cases is adding pressure on the already-stressed health infrastructure around the world
The objective of the research is to understand the drug pricing methodology adopted in the international market covering at least 10 countries, including China, Sri Lanka, Bangladesh and the United States
The first study claiming HCQ is effective against COVID was criticised by science fraud expert Elisabeth Bik, who questioned the ethics, timelines for the trials, a lack of randomisation for patients and missing data